1-201365636-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM5PP3_Moderate
The NM_001276345.2(TNNT2):c.268C>A(p.Pro90Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P90S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001276345.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNNT2 | NM_001276345.2 | c.268C>A | p.Pro90Thr | missense_variant | 9/17 | ENST00000656932.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNNT2 | ENST00000656932.1 | c.268C>A | p.Pro90Thr | missense_variant | 9/17 | NM_001276345.2 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 4 Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostics Centre, Carl Von Ossietzky University Oldenburg | Jun 02, 2023 | The variant TNNT2:c.238C>A, p.(Pro80Thr), which is located in the coding exon 8 of the TNNT2 gene, results from a cytosine to adenine substitution at nucleotide position 238. The proline residue at protein position 80 is replaced by a Threonine. The affected protein region has been postulated as a hotspot region for Pathogenic and Likely Pathogenic variants associated with hypertrophic cardiomyopathy (PMID: 30696458). The variant colocalises with other Pathogenic variants [p.(Pro80Ser; ClinVarID: 43620 and p.(Pro80Leu); ClinVarID: 181641)] that have been described in ClinVar. In silico tools predict a deleterious effect on the protein structure and function (REVEL = 0.81). The variant is very rare in the overall population (no carriers in gnomAD, v4.1.0). In summary, the variant is classified as Likely pathogenic. - |
Dilated cardiomyopathy 1D Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jan 12, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 20, 2018 | The P80T variant of uncertain significance in the TNNT2 gene has not been published as pathogenic or benign to our knowledge. P80T is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution also occurs at a position that is conserved across species, and in silico analysis predicts P80T is probably damaging to the protein structure/function. Furthermore, P80T is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant has also been identified in individuals referred for HCM genetic testing at GeneDx; however, segregation studies have been uninformative thus far. Moreover, while a variant in the same residue (P80S) has been reported to segregate with disease in a family with HCM and LVNC, the proband was also found to harbor a second variant in TNNT2 that likely contributed to his phenotype (Otsuka H et al., 2012). Thus, P80T lacks observation in a significant number of affected individuals, segregation data, and functional evidence, which would further clarify its pathogenicity.Therefore, additional evidence is needed to determine whether this variant is pathogenic or benign. - |
Cardiomyopathy, familial restrictive, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Hypertrophic cardiomyopathy 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Dilated cardiomyopathy 1D;C1861864:Hypertrophic cardiomyopathy 2;C2676271:Cardiomyopathy, familial restrictive, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 11, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 181611). This missense change has been observed in individual(s) with clinical features of TNNT2-related conditions (PMID: 31737537). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with threonine at codon 80 of the TNNT2 protein (p.Pro80Thr). The proline residue is highly conserved and there is a small physicochemical difference between proline and threonine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at